Comparison of Off-pump Coronary Artery Bypass Grafting With Percutaneous Coronary Intervention Versus Drug-Eluting Stents for Three-Vessel Coronary Artery Disease

Annals of Thoracic Surgery

Volumn 86, Issue 5, 2008, Pages 1438-1443

  Yi, Gijong ^a   Youn, Young Nam ^b   Yoo, Kyung Jong ^b   Hong, You Sun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OFF PUMP CORONARY SURGERY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOPULMONARY BYPASS; CEREBROVASCULAR DISORDERS; CORONARY ARTERY BYPASS; CORONARY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; RECURRENCE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 53849125055     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.07.040     Document Type: Article

References (22)

1. Moses J.W., Leon M.B., Fitzgerald P.J., et al., SERIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in native coronary artery. N Engl J Med 349 (2003) 1315-1323
2. Stone G.W., Ellis S.G., Cox D.A., et al., TAXUS-IV Investigators. One year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS IV trial. Circulation 109 (2004) 1942-1947
3. Kappetein A.P., Dawkins K.D., Mohr F.W., et al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in-phase. Eur J Cardio-thorac Surg 29 (2006) 486-491
4. Serruys P.W., Ong A.T., Herwrden L.A., et al. Five-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. The final analysis of the arterial revascularization therapies study (ARTS) randomized trial. J Am Coll Cardiol 46 (2005) 575-581
5. Rodriguez A.E., Baldi J., Pereira C.F., et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multi vessel disease (ERACI II). J Am Coll Cardiol 46 (2005) 582-588
6. Babapulle M.N., Joseph L., Bélisle P., Brophy J.M., and Eisenberg M.J. A hierarchial Bayesian meta-analysis of randomized trials of drug-eluting stents. Lancet 364 (2004) 583-591
7. Hannan E.L., Racz M.J., Walford G., et al. Long-term outcomes of coronary artery bypass grafting versus stent implantation. New Engl J Med 352 (2005) 2174-2183
8. Van Domburg R.T., Takkenberg J.J., Noordzij L.J., et al. Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: A single-center matched-propensity controlled cohort study. Ann Thorac Surg 79 (2005) 1563-1569
9. Brener S.J., Lytle B.W., Casserly I.P., Schneider J.P., Topol E.J., and Lauer M.S. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 109 (2004) 2290-2295
10. Hoffman S.N., TenBrook J.A., Wolf M.P., Pauker S.G., Salem D.N., and Wong J.B. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 41 (2003) 1293-1304
11. Hueb W., Lopes N.H., Gersh B.J., et al. Five-year follow-up of the medicine, angioplasty, or surgery study (MASS II). Circulation 115 (2007) 1082-1089
12. Barner H.B. Status of percutaneous coronary intervention and coronary artery bypass. Eur J Cardio-thorac Surg 30 (2006) 419-424
13. Raja S.G. Drug-eluting stents and the future of coronary artery bypass surgery: facts and fiction. Ann Thorac Surg 81 (2006) 1162-1171
14. Reul R.M. Will drug-eluting stents replace coronary artery bypass surgery?. Tex Heart Inst J 32 (2005) 323-330
15. Ben-Gal Y., Mohr R., Uretzky G., et al. Drug-eluting stents versus arterial myocardial revascularization in patients with diabetes mellitus. J Thorac Cardiovasc Surg 132 (2006) 861-866
16. Lee M.S., Jamal F., Kedia G., et al. Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. Int J Cardiol 123 (2007) 34-42
17. Ben-Gal Y., Moshkovitz, Nesher N., et al. Drug-eluting stents versus coronary artery bypass grafting with diabetes mellitus. Ann Thorac Surg 82 (2006) 1692-1697
18. Moshkovitz Y., Mohr R., Braunstein R., et al. Revascularization of left anterior descending coronary artery in patients with single and multivessel disease. Chest 128 (2005) 804-809
19. Briguori C., Condorelli G., Airoldi F., et al. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol 99 (2007) 779-784
20. Salm T.J.V., Kip K.E., Jones R.H., et al. What constitutes optimal surgical revascularization?. Answers from the bypass angioplasty revascularization Investigation (BARI). J Am Coll Cardiol 39 (2002) 562-572
21. Vimani R., Farb A., Guagliumi G., et al. Drug-eluting stents; caution and concerns for long-term outcome. Coron Artery Dis 15 (2004) 313-318
22. McFadden E.P., Stabile E., Regar E., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of anti-platelet therapy. Lancet 364 (2004) 1519-1521